The Filings Report

Colgate-Palmolive Company

CLNYSECIK 21665Consumer Defensive / Household & Personal Productsfiscal year ends December73 quarters since 2008

Revenue, Q2 FY2026
$5.4B
+4.9% on Q2 FY2025
Net income
$693M
−6.7% on Q2 FY2025
Free cash flow
$867M
+11.7% on Q2 FY2025
Diluted EPS
$0.86
−5.5% on Q2 FY2025
Revenue, TTM
$21.0B
trailing four quarters
Net margin, TTM
9.7%
net income $2.0B
Free cash flow, TTM
$3.9B
$4.5B less $598M capex
Cash and equivalents
$1.4B
long-term debt $7.8B, Jun 30, 2026
Shares, 12-month change
−1.4%
797M shares, Jun 30, 2026
Buybacks, TTM
$1.3B
1.7% of market value
Dividends, TTM
—
no yield
Market value
$76.0B
at the close, buybacks

Latest quarter Q2 FY2026, filed July 31, 2026. Trailing figures sum the latest four quarters. Market values at the latest close, from a market data vendor.

In Q2 FY2026, the quarter ended June 30, 2026, Colgate-Palmolive Company reported revenue of $5.4B, +4.9% on Q2 FY2025, and net income of $693M (−6.7%). Operating margin was 19.0%. Free cash flow, operating cash flow less capital expenditures, was $867M ($995M less $128M). Diluted earnings per share were $0.86.

The last 16 quarters

Q3 FY2022 to Q2 FY2026, through the filing of July 31, 2026.

Revenue and net incomeRevenueNet income
−$2B$0$2B$4B$6BQ3'22, Revenue: $4.5BQ3'22, Net income: $618MQ3'22Q4'22, Revenue: $4.6BQ4'22, Net income: $5MQ4'22Q1'23, Revenue: $4.8BQ1'23, Net income: $372MQ1'23Q2'23, Revenue: $4.8BQ2'23, Net income: $502MQ2'23Q3'23, Revenue: $4.9BQ3'23, Net income: $708MQ3'23Q4'23, Revenue: $5.0BQ4'23, Net income: $718MQ4'23Q1'24, Revenue: $5.1BQ1'24, Net income: $683MQ1'24Q2'24, Revenue: $5.1BQ2'24, Net income: $731MQ2'24Q3'24, Revenue: $5.0BQ3'24, Net income: $737MQ3'24Q4'24, Revenue: $4.9BQ4'24, Net income: $739MQ4'24Q1'25, Revenue: $4.9BQ1'25, Net income: $690MQ1'25Q2'25, Revenue: $5.1BQ2'25, Net income: $743MQ2'25Q3'25, Revenue: $5.1BQ3'25, Net income: $735MQ3'25Q4'25, Revenue: $5.2BQ4'25, Net income: −$37MQ4'25Q1'26, Revenue: $5.3BQ1'26, Net income: $646MQ1'26Q2'26, Revenue: $5.4BQ2'26, Net income: $693MQ2'26−$2B$0$2B$4B$6BQ3'22, Revenue: $4.5BQ3'22, Net income: $618MQ4'22, Revenue: $4.6BQ4'22, Net income: $5MQ4'22Q1'23, Revenue: $4.8BQ1'23, Net income: $372MQ2'23, Revenue: $4.8BQ2'23, Net income: $502MQ2'23Q3'23, Revenue: $4.9BQ3'23, Net income: $708MQ4'23, Revenue: $5.0BQ4'23, Net income: $718MQ4'23Q1'24, Revenue: $5.1BQ1'24, Net income: $683MQ2'24, Revenue: $5.1BQ2'24, Net income: $731MQ2'24Q3'24, Revenue: $5.0BQ3'24, Net income: $737MQ4'24, Revenue: $4.9BQ4'24, Net income: $739MQ4'24Q1'25, Revenue: $4.9BQ1'25, Net income: $690MQ2'25, Revenue: $5.1BQ2'25, Net income: $743MQ2'25Q3'25, Revenue: $5.1BQ3'25, Net income: $735MQ4'25, Revenue: $5.2BQ4'25, Net income: −$37MQ4'25Q1'26, Revenue: $5.3BQ1'26, Net income: $646MQ2'26, Revenue: $5.4BQ2'26, Net income: $693MQ2'26

Net income losses drawn in red.

Free cash flow
$0$500M$1.0B$1.5BQ3'22, Free cash flow: $794MQ3'22Q4'22, Free cash flow: $452MQ4'22Q1'23, Free cash flow: $572MQ1'23Q2'23, Free cash flow: $538MQ2'23Q3'23, Free cash flow: $991MQ3'23Q4'23, Free cash flow: $939MQ4'23Q1'24, Free cash flow: $555MQ1'24Q2'24, Free cash flow: $873MQ2'24Q3'24, Free cash flow: $1.0BQ3'24Q4'24, Free cash flow: $1.1BQ4'24Q1'25, Free cash flow: $476MQ1'25Q2'25, Free cash flow: $776MQ2'25Q3'25, Free cash flow: $1.1BQ3'25Q4'25, Free cash flow: $1.3BQ4'25Q1'26, Free cash flow: $609MQ1'26Q2'26, Free cash flow: $867MQ2'26$0$500M$1.0B$1.5BQ3'22, Free cash flow: $794MQ4'22, Free cash flow: $452MQ4'22Q1'23, Free cash flow: $572MQ2'23, Free cash flow: $538MQ2'23Q3'23, Free cash flow: $991MQ4'23, Free cash flow: $939MQ4'23Q1'24, Free cash flow: $555MQ2'24, Free cash flow: $873MQ2'24Q3'24, Free cash flow: $1.0BQ4'24, Free cash flow: $1.1BQ4'24Q1'25, Free cash flow: $476MQ2'25, Free cash flow: $776MQ2'25Q3'25, Free cash flow: $1.1BQ4'25, Free cash flow: $1.3BQ4'25Q1'26, Free cash flow: $609MQ2'26, Free cash flow: $867MQ2'26

Operating cash flow less capital expenditures; negative quarters in red.

Cash and equivalents against long-term debtCash and equivalentsLong-term debt
$0$3B$5B$8B$10BQ3'22, Cash and equivalents: $938MQ3'22, Long-term debt: $8.2BQ3'22Q4'22, Cash and equivalents: $775MQ4'22, Long-term debt: $8.7BQ4'22Q1'23, Cash and equivalents: $867MQ1'23, Long-term debt: $8.9BQ1'23Q2'23, Cash and equivalents: $819MQ2'23, Long-term debt: $9.0BQ2'23Q3'23, Cash and equivalents: $951MQ3'23, Long-term debt: $8.7BQ3'23Q4'23, Cash and equivalents: $966MQ4'23, Long-term debt: $8.2BQ4'23Q1'24, Cash and equivalents: $1.1BQ1'24, Long-term debt: $8.2BQ1'24Q2'24, Cash and equivalents: $1.1BQ2'24, Long-term debt: $8.1BQ2'24Q3'24, Cash and equivalents: $1.2BQ3'24, Long-term debt: $7.9BQ3'24Q4'24, Cash and equivalents: $1.1BQ4'24, Long-term debt: $7.3BQ4'24Q1'25, Cash and equivalents: $1.1BQ1'25, Long-term debt: $6.6BQ1'25Q2'25, Cash and equivalents: $1.2BQ2'25, Long-term debt: $7.1BQ2'25Q3'25, Cash and equivalents: $1.3BQ3'25, Long-term debt: $7.3BQ3'25Q4'25, Cash and equivalents: $1.3BQ4'25, Long-term debt: $6.9BQ4'25Q1'26, Cash and equivalents: $1.3BQ1'26, Long-term debt: $7.9BQ1'26Q2'26, Cash and equivalents: $1.4BQ2'26, Long-term debt: $7.8BQ2'26$0$3B$5B$8B$10BQ3'22, Cash and equivalents: $938MQ3'22, Long-term debt: $8.2BQ4'22, Cash and equivalents: $775MQ4'22, Long-term debt: $8.7BQ4'22Q1'23, Cash and equivalents: $867MQ1'23, Long-term debt: $8.9BQ2'23, Cash and equivalents: $819MQ2'23, Long-term debt: $9.0BQ2'23Q3'23, Cash and equivalents: $951MQ3'23, Long-term debt: $8.7BQ4'23, Cash and equivalents: $966MQ4'23, Long-term debt: $8.2BQ4'23Q1'24, Cash and equivalents: $1.1BQ1'24, Long-term debt: $8.2BQ2'24, Cash and equivalents: $1.1BQ2'24, Long-term debt: $8.1BQ2'24Q3'24, Cash and equivalents: $1.2BQ3'24, Long-term debt: $7.9BQ4'24, Cash and equivalents: $1.1BQ4'24, Long-term debt: $7.3BQ4'24Q1'25, Cash and equivalents: $1.1BQ1'25, Long-term debt: $6.6BQ2'25, Cash and equivalents: $1.2BQ2'25, Long-term debt: $7.1BQ2'25Q3'25, Cash and equivalents: $1.3BQ3'25, Long-term debt: $7.3BQ4'25, Cash and equivalents: $1.3BQ4'25, Long-term debt: $6.9BQ4'25Q1'26, Cash and equivalents: $1.3BQ1'26, Long-term debt: $7.9BQ2'26, Cash and equivalents: $1.4BQ2'26, Long-term debt: $7.8BQ2'26

Positions at each quarter end, as filed; short-term investments are not included.

Income statement

Last eight quarters, newest first, through Q2 FY2026 filed July 31, 2026.

Colgate-Palmolive Company income statement, quarterly
Millions of dollarsQ2 FY2026ended Jun 30, 2026filed Jul 31, 2026Q1 FY2026ended Mar 31, 2026filed May 1, 2026Q4 FY2025ended Dec 31, 2025filed Feb 23, 2026Q3 FY2025ended Sep 30, 2025filed Oct 31, 2025Q2 FY2025ended Jun 30, 2025filed Aug 1, 2025Q1 FY2025ended Mar 31, 2025filed Apr 25, 2025Q4 FY2024ended Dec 31, 2024filed Feb 13, 2025Q3 FY2024ended Sep 30, 2024filed Oct 25, 2024YoYQ2 FY2026vs Q2 FY2025
Revenue5,3615,3245,2305,1315,1104,9114,9455,033+4.9%
Cost of revenue2,0652,0982,0842,0822,0411,9241,9631,959+1.2%
Gross profit3,2963,2263,1463,0493,0692,9872,9823,074+7.4%
Research and development—————————
Selling, general and administrative2,1302,0762,0701,9711,9631,8981,8961,979+8.5%
Operating income1,016964921,0591,0801,0761,0631,065−5.9%
Other income (expense)—————————
Pretax income9508921089921,007953993986−5.7%
Income tax231211113226234227214210−1.3%
Net income693646(37)735743690739737−6.7%
Diluted EPS ($)0.860.80—0.910.910.85—0.90−5.5%
Diluted shares (millions)802805—810813815—823—

Fourth quarters are the fiscal year less the first nine months when the filer reports no discrete fourth quarter, and are marked. Diluted EPS is never derived, so a derived quarter shows none. Italic figures are derived.

Balance sheet

Last eight quarters, newest first, through Q2 FY2026 filed July 31, 2026.

Colgate-Palmolive Company balance sheet, quarterly
Millions of dollarsQ2 FY2026ended Jun 30, 2026filed Jul 31, 2026Q1 FY2026ended Mar 31, 2026filed May 1, 2026Q4 FY2025ended Dec 31, 2025filed Feb 23, 2026Q3 FY2025ended Sep 30, 2025filed Oct 31, 2025Q2 FY2025ended Jun 30, 2025filed Aug 1, 2025Q1 FY2025ended Mar 31, 2025filed Apr 25, 2025Q4 FY2024ended Dec 31, 2024filed Feb 13, 2025Q3 FY2024ended Sep 30, 2024filed Oct 25, 2024YoYQ2 FY2026vs Q2 FY2025
Cash and equivalents1,3701,3351,2881,2791,2151,1121,0961,234+12.8%
Short-term investments——107———160——
Total current assets6,3086,0825,7096,0395,9965,8145,3175,806+5.2%
Total assets16,79016,61016,33017,51317,47016,64716,04616,774−3.9%
Total current liabilities6,1485,9346,8536,4966,7756,8615,7595,565−9.3%
Long-term debt7,8237,9376,8717,3067,1446,5717,2897,909+9.5%
Total liabilities16,22416,12415,96516,27516,41815,91415,50215,938−1.2%
Stockholders’ equity23614554856702363212435−66.4%
Shares outstanding (millions)797800802806808810812817—

Positions at each period end. Nothing on this statement is derived. Long-term debt is the filed noncurrent line only; no total-debt composite is constructed across filers. Italic figures are derived.

Cash flow statement

Last eight quarters, newest first, through Q2 FY2026 filed July 31, 2026.

Colgate-Palmolive Company cash flow statement, quarterly
Millions of dollarsQ2 FY2026ended Jun 30, 2026filed Jul 31, 2026Q1 FY2026ended Mar 31, 2026filed May 1, 2026Q4 FY2025ended Dec 31, 2025filed Feb 23, 2026Q3 FY2025ended Sep 30, 2025filed Oct 31, 2025Q2 FY2025ended Jun 30, 2025filed Aug 1, 2025Q1 FY2025ended Mar 31, 2025filed Apr 25, 2025Q4 FY2024ended Dec 31, 2024filed Feb 13, 2025Q3 FY2024ended Sep 30, 2024filed Oct 25, 2024YoYQ2 FY2026vs Q2 FY2025
Operating cash flow9957471,4531,2618846001,2691,167+12.6%
Capital expenditures128138177155108124184134+18.5%
Free cash flow (CFO − capex)8676091,2761,1067764761,0851,033+11.7%
Depreciation and amortization155156173158151148148150+2.6%
Share repurchases291306406288232284455295+25.4%
Dividends paid—————————

10-Qs file cash flows as year-to-date totals, so quarterly figures are differenced from consecutive filings and marked. Free cash flow is operating cash flow less capital expenditures, computed from the two filed lines. Italic figures are derived.

Annual statements

Every fiscal year filed, newest first, through FY2025 filed February 23, 2026.

Income statement

Colgate-Palmolive Company income statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 23, 2026FY2024ended Dec 31, 2024filed Feb 13, 2025FY2023ended Dec 31, 2023filed Feb 15, 2024FY2022ended Dec 31, 2022filed Feb 16, 2023FY2021ended Dec 31, 2021filed Feb 17, 2022FY2020ended Dec 31, 2020filed Feb 18, 2021FY2019ended Dec 31, 2019filed Feb 21, 2020FY2018ended Dec 31, 2018filed Feb 21, 2019FY2017ended Dec 31, 2017filed Feb 15, 2018FY2016ended Dec 31, 2016filed Feb 23, 2017FY2015ended Dec 31, 2015filed Feb 18, 2016FY2014ended Dec 31, 2014filed Feb 19, 2015FY2013ended Dec 31, 2013filed Feb 20, 2014FY2012ended Dec 31, 2012filed Feb 21, 2013FY2011ended Dec 31, 2011filed Feb 23, 2012FY2010ended Dec 31, 2010filed Feb 25, 2010FY2009ended Dec 31, 2009filed Feb 25, 2010FY2008ended Dec 31, 2008filed Jul 30, 2009FY2007ended Dec 31, 2007filed Jul 30, 2009
Revenue20,38220,10119,45717,96717,42116,47115,69315,54415,45415,19516,03417,27717,42017,08516,73415,56415,32715,33013,790
Cost of revenue8,1317,9408,1317,7197,0466,4546,3686,3136,1746,0726,6357,1687,2197,1537,1446,3606,3196,7046,043
Gross profit12,25112,16111,32610,24810,37510,0179,3259,2319,2809,1239,39910,10910,2019,9329,5909,2049,0088,6267,747
Research and development366355343320307290281277285289274277267259262256256240—
Selling, general and administrative7,9037,7297,1516,5656,4076,0195,5755,3895,4005,1435,4645,9826,2235,9305,7585,4145,2825,4224,973
Operating income3,3064,2683,9842,8933,3323,8853,5543,6943,7073,9552,7893,5573,5563,8893,8413,4893,6153,1012,720
Other income (expense)———————————————————
Pretax income3,0593,9563,3922,6603,0873,6473,3013,4643,4873,7382,7633,5333,5653,8743,7893,4303,538——
Income tax7989079376937497877749061,3131,1521,2151,1941,1551,2431,2351,1171,141968759
Net income2,1322,8892,3001,7852,1662,6952,3672,4002,0242,4411,3842,1802,2412,4722,4312,2032,2911,9571,737
Diluted EPS ($)2.633.512.772.132.553.142.752.752.282.721.522.362.382.572.472.15*2.19*1.83*1.60*
Diluted shares (millions)8118238298398488598618738888989109249409609841,022*1,049*1,070*—

Balance sheet

Colgate-Palmolive Company balance sheet, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 23, 2026FY2024ended Dec 31, 2024filed Feb 13, 2025FY2023ended Dec 31, 2023filed Feb 15, 2024FY2022ended Dec 31, 2022filed Feb 16, 2023FY2021ended Dec 31, 2021filed Feb 17, 2022FY2020ended Dec 31, 2020filed Feb 18, 2021FY2019ended Dec 31, 2019filed Feb 21, 2020FY2018ended Dec 31, 2018filed Feb 21, 2019FY2017ended Dec 31, 2017filed Feb 15, 2018FY2016ended Dec 31, 2016filed Feb 23, 2017FY2015ended Dec 31, 2015filed Feb 18, 2016FY2014ended Dec 31, 2014filed Feb 19, 2015FY2013ended Dec 31, 2013filed Feb 20, 2014FY2012ended Dec 31, 2012filed Feb 21, 2013FY2011ended Dec 31, 2011filed Feb 23, 2012FY2010ended Dec 31, 2010filed Feb 25, 2010FY2009ended Dec 31, 2009filed Feb 25, 2010FY2008ended Dec 31, 2008filed Jul 30, 2009FY2007ended Dec 31, 2007filed Jul 30, 2009
Cash and equivalents1,2881,0969667758328888837261,5351,3159701,089962884878490600555429
Short-term investments107160179————————————————
Total current assets5,7095,3175,2795,1134,3974,3384,1793,7934,6394,3384,3844,8634,9314,5564,4023,7303,8103,710—
Total assets16,33016,04616,39315,73115,04015,92015,03412,16112,67612,12311,93513,44013,98513,39412,72411,17211,1349,979—
Total current liabilities6,8535,7594,7414,0044,0514,4044,0383,3413,4083,3053,5343,9464,5793,7363,7163,7283,5992,952—
Long-term debt6,8717,2898,2198,7417,1947,3347,3336,3546,5666,5206,2465,6444,7494,9264,4302,8153,147——
Total liabilities15,96515,50215,43614,92514,06914,81914,47611,96412,43312,10611,97912,07411,44911,00410,1838,3557,8777,935—
Stockholders’ equity54212609401609743117(102)(60)(243)(299)1,1452,3052,1892,3752,6753,1161,923—
Shares outstanding (millions)802812823830840849855862875883893907919935*959*987*981*——

Cash flow statement

Colgate-Palmolive Company cash flow statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 23, 2026FY2024ended Dec 31, 2024filed Feb 13, 2025FY2023ended Dec 31, 2023filed Feb 15, 2024FY2022ended Dec 31, 2022filed Feb 16, 2023FY2021ended Dec 31, 2021filed Feb 17, 2022FY2020ended Dec 31, 2020filed Feb 18, 2021FY2019ended Dec 31, 2019filed Feb 21, 2020FY2018ended Dec 31, 2018filed Feb 21, 2019FY2017ended Dec 31, 2017filed Feb 15, 2018FY2016ended Dec 31, 2016filed Feb 23, 2017FY2015ended Dec 31, 2015filed Feb 18, 2016FY2014ended Dec 31, 2014filed Feb 19, 2015FY2013ended Dec 31, 2013filed Feb 20, 2014FY2012ended Dec 31, 2012filed Feb 21, 2013FY2011ended Dec 31, 2011filed Feb 23, 2012FY2010ended Dec 31, 2010filed Feb 25, 2010FY2009ended Dec 31, 2009filed Feb 25, 2010FY2008ended Dec 31, 2008filed Jul 30, 2009FY2007ended Dec 31, 2007filed Jul 30, 2009
Operating cash flow4,1984,1073,7452,5563,3253,7193,1333,0563,0543,1412,9493,2983,2043,1962,8963,2113,2772,3022,252
Capital expenditures564561705696567409335436553593691757670565537550575684583
Free cash flow (CFO − capex)3,6343,5463,0401,8602,7583,3102,7982,6202,5012,5482,2582,5412,5342,6312,3592,6612,7021,6181,669
Depreciation and amortization630605567545556539519511475443449442439425421376351348334
Share repurchases1,2101,7391,1281,3081,3201,4761,2021,2381,3991,3351,5511,5301,5211,9431,8062,0201,0631,0731,269
Dividends paid———————————————————

Insider activity

Form 4 filings by officers, directors and 10% owners, November 1, 2024 to November 1, 2026. Only open-market purchases and sales count as buys and sells; awards, exercises, tax withholding and gifts are listed in grey and never counted.

Bought, three months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, three months
$31M
4 sales by 3 insiders; officers and directors $31M
Bought, twelve months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, twelve months
$57M
15 sales by 8 insiders; officers and directors $57M

The last 25 transactions

TradedInsiderRoleTransactionSharesPriceValueHeld afterFiled
Oct 1, 2026Norrington Lorrie MDirectoraward300$87.42$26K43,310Oct 2, 2026
Oct 1, 2026Newman BrianDirectoraward214$87.42$19K8,058Oct 2, 2026
Oct 1, 2026Bilbrey John PDirectoraward271$87.42$24K40,725Oct 2, 2026
Sep 16, 2026Wallace Noel R.Chairman, President & CEO, Directoraward29,649$0.00—379,700Sep 18, 2026
Sep 16, 2026Grant ShaneCOO, Americasaward7,355$0.00—79,503Sep 18, 2026
Sep 16, 2026Tsourapas PanagiotisCOO, CD, EMEA, APac, Skinaward4,597$0.00—11,447Sep 18, 2026
Sep 16, 2026Sutula Stanley J IIIChief Financial Officeraward8,045$0.00—79,029Sep 18, 2026
Sep 16, 2026Hazlin JohnChief Growth Officeraward3,908$0.00—27,021Sep 18, 2026
Sep 16, 2026Massey SallyChief People Officeraward3,333$0.00—15,397Sep 18, 2026
Sep 16, 2026Fishbone BetsyCLO and Secretaryaward2,207$0.00—16,050Sep 18, 2026
Sep 16, 2026Malcolm GregoryEVP and Controlleraward1,081$0.00—14,162Sep 18, 2026
Sep 13, 2026Wallace Noel R.Chairman, President & CEO, Directortax withholding4,892$86.80$425K350,051Sep 15, 2026
Sep 13, 2026Tsourapas PanagiotisCOO, CD, EMEA, APac, Skintax withholding922$86.80$80K6,850Sep 15, 2026
Sep 13, 2026Sutula Stanley J IIIChief Financial Officertax withholding1,385$86.80$120K70,984Sep 15, 2026
Sep 13, 2026Massey SallyChief People Officertax withholding686$86.80$60K12,064Sep 15, 2026
Sep 13, 2026Malcolm GregoryEVP and Controllertax withholding225$86.80$20K13,081Sep 15, 2026
Sep 13, 2026Hazlin JohnChief Growth Officertax withholding499$86.80$43K23,113Sep 15, 2026
Sep 13, 2026Fishbone BetsyCLO and Secretarytax withholding472$86.80$41K13,843Sep 15, 2026
Sep 12, 2026Wallace Noel R.Chairman, President & CEO, Directortax withholding3,516$86.80$305K354,943Sep 15, 2026
Sep 12, 2026Tsourapas PanagiotisCOO, CD, EMEA, APac, Skintax withholding618$86.80$54K7,772Sep 15, 2026
Sep 12, 2026Sutula Stanley J IIIChief Financial Officertax withholding927$86.80$80K72,369Sep 15, 2026
Sep 12, 2026Massey SallyChief People Officertax withholding459$86.80$40K12,750Sep 15, 2026
Sep 12, 2026Malcolm GregoryEVP and Controllertax withholding151$86.80$13K13,306Sep 15, 2026
Sep 12, 2026Hazlin JohnChief Growth Officertax withholding439$86.80$38K23,612Sep 15, 2026
Sep 12, 2026Fishbone BetsyCLO and Secretarytax withholding331$86.80$29K14,315Sep 15, 2026

Full insider history for Colgate-Palmolive Company, or insider activity across all companies. A record of filings, not a recommendation.

Sources

Fiscal year ends in month 12; periods are labeled with the issuer's own fiscal calendar. Values are as most recently filed (restatements apply; per-share values are on current split basis per the connector's split table, flagged in adjusted). Flow items flagged in `derived` were computed (Q4 = FY − nine months; quarterly cash flow differenced from year-to-date filings) rather than read from a filing. `reconciliation.repaired` lists periods where a full-year figure was filed in a quarter slot: that row was dropped and the quarter rebuilt from the annual figure. `reconciliation.quarantined` lists periods where four filed quarters do not sum to the filed year — those quarterly values are withheld, so a blank there is a withholding rather than an absence of reporting.

Filer
COLGATE-PALMOLIVE COMPANY, CIK 21665 on EDGAR
Extract generated
August 27, 2026
Withheld
none
Repaired
none
XBRL concepts behind each line

Income statement

Revenue: RevenueFromContractWithCustomerExcludingAssessedTax, SalesRevenueNet
Cost of revenue: CostOfRevenue
Gross profit: GrossProfit
Research and development: ResearchAndDevelopmentExpense
Selling, general and administrative: SellingGeneralAndAdministrativeExpense
Operating income: OperatingIncomeLoss
Other income (expense): not filed
Pretax income: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest, IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
Income tax: IncomeTaxExpenseBenefit
Net income: NetIncomeLoss
Diluted EPS ($): EarningsPerShareDiluted
Diluted shares (millions): WeightedAverageNumberOfDilutedSharesOutstanding

Balance sheet

Cash and equivalents: CashAndCashEquivalentsAtCarryingValue
Short-term investments: MarketableSecuritiesCurrent
Total current assets: AssetsCurrent
Total assets: Assets
Total current liabilities: LiabilitiesCurrent
Long-term debt: LongTermDebt, LongTermDebtNoncurrent
Total liabilities: Liabilities
Stockholders’ equity: StockholdersEquity
Shares outstanding (millions): dei:EntityCommonStockSharesOutstanding

Cash flow statement

Operating cash flow: NetCashProvidedByUsedInOperatingActivities
Capital expenditures: PaymentsToAcquireProductiveAssets, PaymentsToAcquirePropertyPlantAndEquipment
Free cash flow (CFO − capex): not filed
Depreciation and amortization: DepreciationDepletionAndAmortization
Share repurchases: PaymentsForRepurchaseOfCommonStock
Dividends paid: not filed

The data

The statements on this page as files, generated August 27, 2026.

JSON file
/data/financials/CL.json